INVO Bioscience Financials

INVODelisted Stock  USD 0.84  0.03  3.45%   
Based on the measurements of operating efficiency obtained from INVO Bioscience's historical financial statements, INVO Bioscience is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.
  
Understanding current and past INVO Bioscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of INVO Bioscience's financial statements are interrelated, with each one affecting the others. For example, an increase in INVO Bioscience's assets may result in an increase in income on the income statement.

INVO Bioscience Stock Summary

INVO Bioscience competes with Entera Bio, NLS Pharmaceutics, Enveric Biosciences, Lixte Biotechnology, and CLPS. INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. The company was founded in 2007 and is based in Sarasota, Florida. Invo Bioscience operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS44984F3029
Business Address5582 Broadcast Court,
New SymbolNAYA
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.invobioscience.com
Phone978 878 9505
CurrencyUSD - US Dollar

INVO Bioscience Key Financial Ratios

INVO Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining INVO Bioscience's current stock value. Our valuation model uses many indicators to compare INVO Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across INVO Bioscience competition to find correlations between indicators driving INVO Bioscience's intrinsic value. More Info.
INVO Bioscience is rated below average in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the INVO Bioscience's earnings, one of the primary drivers of an investment's value.

INVO Bioscience Market Pulse

 Quote0.84
 Change(%)  3.45 
 Change0.03 
 Open0.87
 Low0.8
 High0.87
 Volume0
 ExchangeNASDAQ

INVO Bioscience November 22, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of INVO Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of INVO Bioscience. We use our internally-developed statistical techniques to arrive at the intrinsic value of INVO Bioscience based on widely used predictive technical indicators. In general, we focus on analyzing INVO Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build INVO Bioscience's daily price indicators and compare them against related drivers.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in INVO Stock

If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world